Intellia Therapeutics (NTLA) CEO pay: $3.2M actually paid in FY2025
$NTLA · Intellia Therapeutics, Inc.Data through FY2025 — latest proxy filed 2026-04-30, checked for new filings 2026-08-21. Every number links to its source.
0.8× the tracked-company median CEO pay ($3.9M).
Pay vs. Performance (Compensation Actually Paid)
What the CEO was actually paid, by fiscal year
A negative figure is not pay returned. Compensation Actually Paid re-values unvested equity every year, so when a stock falls, the write-down on awards granted earlier can exceed everything granted that year. How CAP is calculated
What $100 invested was worth, company vs peer group
Pay-vs-Performance table
| FY | CEO pay on paper | CEO pay actually earned | Other top execs (avg) | Value of $100 invested since FY2020 | Same, peer group since FY2020 | Net income |
|---|---|---|---|---|---|---|
| 2025 | $5.1M | $3.2M | $1.4M | $16.53 | $187.14 | -$412.7M |
| 2024 | $15.3M | $353,494 | $335,175 | $79.48 | $118.20 | -$519.0M |
| 2023 | $11.7M | $8.3M | $2.9M | $207.84 | $118.87 | -$481.2M |
| 2022 | $10.1M | -$14.1M | -$4.9M | $237.83 | $113.65 | -$474.2M |
| 2021 | $9.8M | $37.8M | $16.1M | $806.00 | $126.45 | -$267.9M |
| 2020 | $3.6M | $19.3M | $7.5M | $370.82 | $126.42 | -$134.2M |
A negative figure is not pay returned. Compensation Actually Paid re-values unvested equity every year, so when a stock falls, the write-down on awards granted earlier can exceed everything granted that year. How CAP is calculated
Frequently asked
How much did the NTLA CEO make in 2025?
$3,244,803 in Compensation Actually Paid (CAP) as Intellia Therapeutics, Inc.'s CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2026-04-30.
What is pay vs. performance (PvP)?
An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.
What is Compensation Actually Paid (CAP)?
CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.
Also on NTLA: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary